Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing
antibody and T cell responses after Omicron bivalent booster vaccination
in previously infected and infection-naive individuals
Willem A. Mak 1 (ashwinmak98@gmail.com)
Wendy Visser 1 (wwendy.visser@gmail.com)
Marijke van der Vliet 1 (m.vandervliet@franciscus.nl)
Hilde Y. Markus 1 (hildemarkus@gmail.com)
Johannes G.M. Koeleman 1 (h.koeleman@franciscus.nl)
David S.Y. Ong 1,2 *
a Department of Medical Microbiology and Infection
Control, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands
b Department of Epidemiology, Julius Center for Health
Sciences and Primary Care, University Medical Center Utrecht, Utrecht,
The Netherlands
* Corresponding author: David S.Y. Ong, MD, PhD, PharmD, MSc
Email: davidsyong@gmail.com
Tel.: +31 10 461 6076
Kleiweg 500, 3045PM Rotterdam, The Netherlands
Word count: 2500
Keywords: Omicron, SARS-CoV-2, COVID-19, antibodies, T cells,
vaccination